Multiple Manufacturers

NEOSTIGMINE METHYLSULFATE

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Multiple Manufacturers

Neostigmine Methylsulfate HCPCS:

J2710

HCPCS Code Descriptor:

Injection, neostigmine methylsulfate, up to 0.5 mg

Category:

J Code

Neostigmine Methylsulfate NDCs:

51754-1210-03, 25021-0611-10, 31722-0995-31, 71288-0501-11, 71288-0500-11, 25021-0610-10, 00641-6150-10, 70069-0805-10, 42023-0188-10, 31722-0995-10

Primary Type:

Unclassified

Generic/Specialty Status:

Multi-Source

Package Type:

Multiple

Route of Administration:

Intravenous

Neostigmine Methylsulfate CPT Codes:

Some of the most common CPT administration codes for 'buy and bill' drugs can be found at the following link:

Potential NDC Listing Errors:

We have identified listing errors with the following NDCs:

23155-0518-41, 23155-0517-41, 42023-0188-10, 70069-0805-10, 00641-6150-10, 25021-0610-10, 71288-0500-11, 71288-0501-11, 31722-0995-31, 25021-0611-10, 51754-1210-03

About Neostigmine Methylsulfate:

NEOSTIGMINE METHYLSULFATE is a medication manufactured by multiple manufacturers and aligned to the J Code: J2710. NEOSTIGMINE METHYLSULFATE is administered via the intravenous route of administration.

ACCESS PRICING AND MORE BY REGISTERING

J2710 Added Date:

January 1, 1982

J2710 Effective Date:

January 1, 1997

J2710 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Neostigmine Methylsulfate billing and coding information.
Our team did not identify a source for Neostigmine Methylsulfate patient assistance information. Please reach out to our team if you feel that this is a mistake.
NEOSTIGMINE METHYLSULFATE prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date.
Our team has not yet identified a source of side effects information for NEOSTIGMINE METHYLSULFATE. Please check back in a few weeks.